LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Gharibi, Borzo; Abraham, Anju Ann; Ham, Jack; Evans, Bronwen Alice James (2011)
Publisher: Wiley Blackwell
Languages: English
Types: Article
Subjects: QH426, R1
Identifiers:doi:10.1002/jbmr.424
Osteoblasts and adipocytes differentiate from a common precursor cell, the mesenchymal stem cell (MSC). Adenosine is known to signal via four adenosine receptor subtypes, and significantly, recent findings indicate that these may play a role in MSC differentiation. We therefore investigated adenosine receptor expression and activation during the differentiation of MSCs to osteoblasts and adipocytes. The A2BR was dominant in MSCs, and its expression and activity were transiently upregulated at early stages of osteoblastic differentiation. Both activation and overexpression of A2BR induced the expression of osteoblast-related genes [Runx2 and alkaline phosphatase (ALP)], as well as ALP activity, and stimulation increased osteoblast mineralization. The expression of A2AR was upregulated during later stages of osteoblastic differentiation, when its activation stimulated ALP activity. Differentiation of MSCs to adipocytes was accompanied by significant increases in A1R and A2AR expression, and their activation was associated with increased adipogenesis. Enhanced A2AR expression was sufficient to promote expression of adipocyte-related genes (PPAR and C/EBP), and its activation resulted in increased adipocytic differentiation and lipid accumulation. In contrast, the A1R was involved mainly in lipogenic activity of adipocytes rather than in their differentiation. These results show that adenosine receptors are differentially expressed and involved in lineage-specific differentiation of MSCs. We conclude, therefore, that fruitful strategies for treating diseases associated with an imbalance in the differentiation and function of these lineages should include targeting adenosine receptor signal pathways. Specifically, these research avenues will be useful in preventing or treating conditions with insufficient bone or excessive adipocyte formation.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheum. 2006;2:35-43.
    • 2. Kawai M, Rosen CJ. Bone: adiposity and bone accrual-still an established paradigm? Nat Rev Endocrinol. 2010;6:63-64.
    • 3. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001;226:507-520.
    • 4. Blair HC, Zaidi M, Schlesinger PH. Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J. 2002;364:329-341.
    • 5. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076-1084.
    • 6. Huang W, Yang SY, Shao JZ, Li YP. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci. 2007;12:3068-3092.
    • 7. Otto TC, Lane MD. Adipose Development: From Stem Cell to Adipocyte. Crit Rev Biochem Mol. 2005;40:229-242.
    • 8. Di Iorgi N, Rosol M, Mittelman SD, Gilsanz V. Reciprocal Relation between Marrow Adiposity and the Amount of Bone in the Axial and Appendicular Skeleton of Young Adults. J Clin Endocrinol Metab. 2008;93:2281-2286.
    • 9. Di Iorgi N, Mo AO, Grimm K, Wren TAL, Dorey F, Gilsanz V. Bone Acquisition in Healthy Young Females Is Reciprocally Related to Marrow Adiposity. J Clin Endocrinol Metab. 2010;95:2977-2982.
    • 10. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol. 2002;55:693-698.
    • 11. Qiu W, Andersen TE, Bollerslev J, Mandrup S, Abdallah BM, Kassem M. Patients With High Bone Mass Phenotype Exhibit Enhanced Osteoblast Differentiation and Inhibition of Adipogenesis of Human Mesenchymal Stem Cells. J Bone Miner Res. 2007;22:1720-1731.
    • 12. Valentin D, Aline M, Lafage-Proust M-H, et al. Mechanical Loading Down-Regulates Peroxisome Proliferator-Activated Receptor g in Bone Marrow Stromal Cells and Favors Osteoblastogenesis at the Expense of Adipogenesis. Endocrinology. 2007;148:2553-2562.
    • 13. Fredholm BB. Adenosine receptors as drug targets. Exp Cell Res. 2010;316:1284-1288.
    • 14. Evans BAJ, Elford C, Pexa A, et al. Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL-6 and Osteoprotegerin. J Bone Miner Res. 2006;21:228-236.
    • 15. Montesinos MC, Gadangi P, Longaker M, et al. Wound healing is accelerated by agonists of adenosine A(2) (G(alphas)-linked) receptors. J Exp Med. 1997;186:1615-1620.
    • 16. Linden J. Molecular approach to adenosine receptors: ReceptorMediated Mechanisms of Tissue Protection. Ann Rev Pharmacol. 2001;41:775-787.
    • 17. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414:916-920.
    • 18. Montesinos MC, Desai A, Chen J-F, et al. Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors. Am J Pathol. 2002;160:2009- 2018.
    • 19. Katebi M, Soleimani M, Cronstein BN. Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukocyte Biol. 2009;85:438-444.
    • 20. Vassaux G, Gaillard D, Mari B, Ailhaud G, Negrel R. Differential Expression of Adenosine-A1 and Adenosine-A2 Receptors in Preadipocytes and Adipocytes. Biochem Biophysl Res Co. 1993;193:1123- 1130.
    • 21. Børglum JD, Vassaux G, Richelsen B, et al. Changes in adenosine A1- and A2-receptor expression during adipose cell differentiation. Mol Cell Endocrinol. 1996;117:17-25.
    • 22. Rice AM, Fain JN, Rivkees SA. A1 Adenosine Receptor Activation Increases Adipocyte Leptin Secretion. Endocrinology. 2000;141: 1442-1445.
    • 23. Dong Q, Ginsberg HN, Erlanger BF. Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesityrelated insulin resistance. Diabetes Obes Metab. 2001;3:360- 366.
    • 24. Sen A, Lea-Currie YR, Sujkowska D, et al. Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem. 2001;81:312-319.
    • 25. Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M. Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol. 2001;18:81- 85.
    • 26. Hyde RJ, Cass CE, Young JD, Baldwin SA. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol. 2001;18:53-63.
    • 27. Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 2001; 79:463-484.
    • 28. Ferro F, Falini G, Spelat R, et al. Biochemical and biophysical analyses of tissue-engineered bone obtained from three-dimensional culture of a subset of bone marrow mesenchymal stem cells. Tissue Eng Part A. 2010;16:3657-3667.
    • 29. Mohamadnejad M, Sohail MA, Watanabe A, Krause DS, Swenson ES, Mehal WZ. Adenosine inhibits chemotaxis and induces hepatocytespecific genes in bone marrow mesenchymal stem cells. Hepatology. 2010;51:963-973.
    • 30. Russell J, Stephenson G, Yellowley C, Benton H. Adenosine Inhibition of Lipopolysaccharide-Induced Interleukin-6 Secretion by the Osteoblastic Cell Line MG-63. Calcif Tissue Int. 2007;81: 316-326.
    • 31. Fatokun AA, Stone TW, Smith RA. Hydrogen peroxide-induced oxidative stress in MC3T3-E1cells: The effects of glutamate and protection by purines. Bone. 2006;39:542-551.
    • 32. Larsen KH, Frederiksen CM, Burns JS, Abdallah BM, Kassem M. Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res. 2010;25:796- 808.
    • 33. Fatholahi M, Xiang Y, Wu Y, et al. A Novel Partial Agonist of the A1 - Adenosine Receptor and Evidence of Receptor Homogeneity in Adipocytes. J Pharmacol Exp Ther. 2006;317:676-684.
    • 34. Dhalla AK, Chisholm JW, Reaven GM, Belardinelli L. A1 Adenosine Receptor: Role in Diabetes and Obesity. Handb Exp Pharmacol. 2009;193:271-295.
    • 35. Dhalla AK, Shryock JC, Shreeniwas R, Belardinelli L. Pharmacology and Therapeutic Applications of A1 Adenosine Receptor Ligands. Curr Top Med Chem. 2003;3:369-385.
    • 36. Dhalla AK, Santikul M, Smith M, Wong M-Y, Shryock JC, Belardinelli L. Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid. J Pharmacol Exp Ther. 2007;321:327-333.
    • 37. Barakat H, Davis J, Lang D, Mustafa SJ, McConnaughey MM. Differences in the Expression of the Adenosine A1 Receptor in Adipose Tissue of Obese Black and White Women. J Clin Endocrinol Metab. 2006;91:1882-1886.
    • 38. Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, Doskeland SO, Kristiansen K. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol. 2008;28:3804-3816.
    • 39. Yang D-C, Tsay H-J, Lin S-Y, Chiou S-H, Li M-J, Chang T-J, Hung S-C. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/ OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One. 2008;3:e1540.
    • 40. Zhang J-W, Klemm DJ, Vinson C, Lane MD. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein b gene during adipogenesis. J Biol Chem. 2004;279:4471-4478.
    • 41. Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno JT Jr, Klemm DJ. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1cells ectopically expressing CCAAT/ enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma2. J Biol Chem. 2006;281:40341-40353.
    • 42. Muruganandan S, Roman A, Sinal C. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cell Mol Life Sci. 2009;66:236-253.
    • 43. Henney NC, Li B, Elford C, et al. A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts. Am J Physiol Cell Physiol. 2009;97:C1397-1408.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article